Hanne Vibeke Hansen Marquart

Medicine & Life Sciences

1. B-Lymphocytes 100%
2. Precursor Cell Lymphoblastic Leukemia-Lymphoma 78%
3. Complement 3d Receptors 60%
4. Complement Membrane Attack Complex 60%
5. Complement Receptors 59%
6. Cell Transplantation 48%
7. Griscelli syndrome type 2 42%
8. Alternative Complement Pathway 41%
9. Leukemia 40%
10. Interleukin-12 Receptors 36%
11. Properdin 34%
12. IgA Deficiency 32%
13. Allogeneic Cells 31%
14. Klinefelter Syndrome 30%
15. Mercaptopurine 29%
16. Hemophagocytic Lymphohistiocytosis 29%
17. Chimerism 27%
18. Lymphopenia 27%
19. Myositis 27%
20. Thymoma 26%
21. Erythrocytes 26%
22. Residual Neoplasm 25%
23. Recurrence 25%
24. Complement Activation 25%
25. Child 25%
26. Cerebrospinal Fluid 25%
27. Otitis Media 24%
28. Mycobacterium 24%
29. Hematology 23%
30. Antigen-Antibody Complex 23%
31. PR-SET Domains 22%
32. Blood Cells 21%
33. Pediatrics 21%
34. Systemic Lupus Erythematosus 20%
35. Multiple Sclerosis 19%
36. Leukocytes 19%
37. Relapsing-Remitting Multiple Sclerosis 19%
38. Monocytes 18%
39. Pneumonia 17%
40. complement C3d,g 16%
41. Bovine Serum Albumin 16%
42. Lymphoma, Large B-Cell, Diffuse 16%
43. Therapeutics 16%
44. Phenotype 15%
45. Lymphocytes 15%
46. Pigmentary Dilution 15%
47. Binding Sites 15%
48. Agammaglobulinemia 15%
49. Randomized Controlled Trials 15%